Literature DB >> 8971612

Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.

R F Frye1, D D Stiff.   

Abstract

A sensitive and reproducible method is described for the determination of the cytochrome P450 enzyme 2E1 substrate chlorzoxazone and its primary metabolite 6-hydroxychlorzoxazone in human plasma and urine. Plasma or diluted urine were acidified, incubated with beta-glucuronidase and then were extracted with diethyl ether. Separation of the analytes was achieved on a C18 column with UV detection set at 283 nm. Excellent linearity was observed over the concentration ranges of 100-3000 ng/ml and 4-400 micrograms/ml in plasma and urine, respectively. The intra-assay variability was < or = 5.1% and the inter-assay variability was < or = 8.2% for each compound in each matrix. The method presented is applicable to pharmacokinetic and pharmacogenetic studies utilizing chlorzoxazone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971612     DOI: 10.1016/s0378-4347(96)00227-7

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  10 in total

1.  Modification of CYP2E1 and CYP3A4 activities in haemoglobin E-beta thalassemia patients.

Authors:  Nuntiya Somparn; Upa Kukongviriyapan; Wichittra Tassaneeyakul; Arunee Jetsrisuparb; Veerapol Kukongviriyapan
Journal:  Eur J Clin Pharmacol       Date:  2006-11-21       Impact factor: 2.953

2.  Spectrofluorimetric assessment of chlorzoxazone and ibuprofen in pharmaceutical formulations by using Eu-tetracycline HCl optical sensor doped in sol-gel matrix.

Authors:  M S Attia; M N Ramsis; L H Khalil; S G Hashem
Journal:  J Fluoresc       Date:  2011-11-09       Impact factor: 2.217

3.  Evaluation of the effect of multiple-dose administration of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist on the major CYP isoform activities in healthy volunteers.

Authors:  Youssef Hijazi; Horst Welker; Albert E Dorr; Karl Frank; Louis M Renzetti; Indravadan Patel
Journal:  Eur J Clin Pharmacol       Date:  2005-12-21       Impact factor: 2.953

4.  In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.

Authors:  Bill J Gurley; Stephanie F Gardner; Martha A Hubbard; D Keith Williams; W Brooks Gentry; Ikhlas A Khan; Amit Shah
Journal:  Clin Pharmacol Ther       Date:  2005-05       Impact factor: 6.875

5.  Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.

Authors:  G J Burckart; R F Frye; P Kelly; R A Branch; A Jain; J J Fung; T E Starzl; R Venkataramanan
Journal:  Clin Pharmacol Ther       Date:  1998-03       Impact factor: 6.875

6.  Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba.

Authors:  Bill J Gurley; Stephanie F Gardner; Martha A Hubbard; D Keith Williams; W Brooks Gentry; Yanyan Cui; Catharina Y W Ang
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.

Authors:  Reginald F Frye; Robert A Branch
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

8.  A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study.

Authors:  Ashish Sharma; Sylvie Pilote; Pierre M Bélanger; Marie Arsenault; Bettina A Hamelin
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

9.  Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats.

Authors:  Sudeep R Bista; Sang Kyu Lee; Dinesh Thapa; Mi Jeong Kang; Young Min Seo; Ju Hyun Kim; Dong Hyeon Kim; Yurngdong Jahng; Jung Ae Kim; Tae Cheon Jeong
Journal:  Toxicol Res       Date:  2008-09-01

10.  Optimization of the in vitro oxidative biotransformation of glimepiride as a model substrate for cytochrome p450 using factorial design.

Authors:  Dipti B Ruikar; Sadhana J Rajput
Journal:  Daru       Date:  2012-09-10       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.